Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 177

The DOI matches its Crossref record.

Drug interaction between St John's wort and nevirapine

de Maat, Monique M. R., Hoetelmans, Richard M. W., Mathôt, Ron A. A., van Gorp, Eric C. M., Meenhorst, Pieter L., Mulder, Jan W., Beijnen, Jos H. · 2001 · AIDS

Abstract

Cases have been reported that suggest that extracts from St John's wort (Hypericum perforatum), mainly used as an antidepressant [1], contain potent inducers of hepatic enzymes, raising the possibility of clinically relevant drug interactions. Recent pharmacokinetic data show substantially decreased exposure to the antiretroviral drug indinavir by the concomitant use of St John's wort, probably because of the induction of the 3A4 isoform of the cytochrome P450 system. St John's wort reduced the area under the plasma concentration versus time curve of indinavir by 57% (SD 19%), and decreased the extrapolated 8 h trough concentration by 81% (SD 16%) in eight healthy volunteers [2]. This interaction has been recognized as being clinically relevant. An interaction study [3] with digoxin suggested induction of the expression of the drug-transporter P-glycoprotein. Compared with placebo, the co-administration of Hypericum extracts significantly decreased digoxin concentrations, an effect that increased with the number of days on Hypericum extracts [3]. In addition to such studies, several case reports [4] have shown decreased plasma concentrations or decreased activity of cyclosporin, oral contraceptives, theophylline and warfarin with the concomitant use of St John's wort. As all of the currently marketed protease inhibitors and non-nucleoside reverse transcriptase inhibitors (NNRTI) are substrates for the multidrug transporter P-glycoprotein and/or are extensively metabolized via the cytochrome P450 enzyme system, the concomitant use of St John's wort may result in decreased exposure to these classes of antiretroviral drugs, with clinical consequences. We present five patients (all men, aged 34–53 years) infected with HIV-1, who had been treated with the NNRTI nevirapine and two nucleoside analogue reverse transcriptase inhibitors for over a year, and who concomitantly used St John's wort for several months. At our clinic, nevirapine plasma concentrations from each patient are routinely measured every 3 months. The five patients had at least one nevirapine plasma concentration with and at least one without St John's wort as co-medication. We noticed that the nevirapine plasma concentrations of these patients were consistently lower on some occasions. To determine whether these lower exposures were caused by the use of St John's wort, a non-linear mixed-effect modelling analysis (NONMEM) was performed [5]. A database consisting of 1330 nevirapine plasma concentrations of 176 patients, collected during 789 visits, was available for this analysis. The pharmacokinetics of nevirapine were described with a one-compartment model with first-order absorption and elimination (Table 1). The median oral clearance was 3.2 l/h, which is in accordance with an earlier reported value [6]. Interindividual and interoccasion (intervisit) variability were 29 and 22%, respectively. With the concomitant use of St John's wort included as a co-variate for oral clearance in the population pharmacokinetic model, the oral clearance of nevirapine was significantly increased with 35% (SE 15%) (P = 0.02) for patients using St John's wort, thus leading to a decreased exposure. None of the five patients in our population used any co-medication that could have resulted in an increased oral clearance. As nevirapine is extensively metabolized via the CYP450 system, the concomitant use of St John's wort can therefore explain the increase in oral clearance.Table 1: Median individual estimates of oral clearance of nevirapine in HIV-1-infected patients. In conclusion, we have shown that St John's wort decreases the exposure to the NNRTI nevirapine by increasing its oral clearance. Because a low exposure to nevirapine may eventually result in antiretroviral resistance and treatment failure [7], the concomitant use of nevirapine and St John's wort should be avoided. Monique M. R. de Maata Richard M. W. Hoetelmansa Ron A. A. Mathôta Eric C. M. van Gorpb Pieter L. Meenhorstb Jan W. Mulderb Jos H. Beijnena

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00002030-200102160-00019

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 177

Metadata

Authors
de Maat, M. M. R., Hoetelmans, R. M. W., Mathôt, R. A. A., van Gorp, E. C. M., Meenhorst, P. L., Mulder, J. W., & Beijnen, J. H.
Venue
AIDS
Published
2001-02
Volume
15
Issue
3
Pages
420-421
ISSN
0269-9370 (ISSN-L)
OpenAlex
W1993633682
Cited by
177
References
0
FWCI
10.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug interaction between St John's wort and nevirapine. https://app.cochat.ai/papers/10.1097/00002030-200102160-00019
The paper
de Maat, M. M. R., Hoetelmans, R. M. W., Mathôt, R. A. A., van Gorp, E. C. M., Meenhorst, P. L., Mulder, J. W., & Beijnen, J. H. (2001). Drug interaction between St John's wort and nevirapine. AIDS. https://doi.org/10.1097/00002030-200102160-00019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.